Articles by tag: pancreatic-cancer

Daraxonacib for Pancreatic Cancer: Risks and Survival

The drug daraxonacib doubled survival in pancreatic cancer but does not cure. Learn about mechanisms, side effects, and real limits of the breakthrough. Read the analysis.

Moderna's personalized mRNA vaccine against pancreatic cancer: 78% effect

Moderna released a personalized mRNA vaccine against pancreatic cancer: remission in 78% of patients over 18 months. FDA accelerated approval. Analysis of efficacy and risks.

Oncolytics Biotech immunotherapy for pancreatic cancer ASCO 2026

Oncolytics Biotech data at ASCO 2026: pelareorep virus activates T cells against mutant KRAS in pancreatic cancer. Learn about the breakthrough in treating 'cold' tumors.